SELECTION FOR TREATMENTS
\sɪlˈɛkʃən fɔː tɹˈiːtmənts], \sɪlˈɛkʃən fɔː tɹˈiːtmənts], \s_ɪ_l_ˈɛ_k_ʃ_ə_n f_ɔː t_ɹ_ˈiː_t_m_ə_n_t_s]\
Sort: Oldest first
-
Criteria and standards used for the determination of the appropriateness of the inclusion of patients with specific conditions in proposed treatment plans and the criteria used for the inclusion of subjects in various clinical trials and other research protocols.
By DataStellar Co., Ltd
Word of the day
bcr v abl Oncogene
- Retrovirus-associated DNA sequences (abl) originally isolated from Abelson murine leukemia virus (Ab-MuLV). proto-oncogene abl (codes for a protein that member tyrosine kinase family. human c-abl gene is located at 9q34.1 on the long arm of chromosome 9. It activated by translocation to bcr 22 in chronic myelogenous leukemia.